Skip to main content
Top
Published in: BMC Cancer 1/2023

Open Access 01-12-2023 | Magnetic Resonance Imaging | Research

Biparametric magnetic resonance imaging-based radiomics features for prediction of lymphovascular invasion in rectal cancer

Authors: Pengfei Tong, Danqi Sun, Guangqiang Chen, Jianming Ni, Yonggang Li

Published in: BMC Cancer | Issue 1/2023

Login to get access

Abstract

Background

Preoperative assessment of lymphovascular invasion(LVI) of rectal cancer has very important clinical significance. However, accurate preoperative imaging evaluation of LVI is highly challenging because the resolution of MRI is still limited. Relatively few studies have focused on prediction of LVI of rectal cancer with the tool of radiomics, especially in patients with negative statue of MRI-based extramural vascular invasion (mrEMVI).The purpose of this study was to explore the preoperative predictive value of biparametric MRI-based radiomics features for LVI of rectal cancer in patients with the negative statue of mrEMVI.

Methods

The data of 146 cases of rectal adenocarcinoma confirmed by postoperative pathology were retrospectively collected. In the cases, 38 had positive status of LVI. All patients were examined by MRI before the operation. The biparametric MRI protocols included T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI). We used whole-volume three-dimensional method and two feature selection methods, minimum redundancy maximum relevance (mRMR) and least absolute shrinkage and selection operator (LASSO), to extract and select the features. Logistics regression was used to construct models. The area under the receiver operating characteristic curve (AUC) and DeLong’s test were used to evaluate the diagnostic performance of the radiomics based on T2WI and DWI and the combined models.

Results

Radiomics models based on T2WI and DWI had good predictive performance for LVI of rectal cancer in both the training cohort and the validation cohort. The AUCs of the T2WI model were 0.87 and 0.87, and the AUCs of the DWI model were 0.94 and 0.92. The combined model was better than the T2WI model, with AUCs of 0.97 and 0.95. The predictive performance of the DWI model was comparable to that of the combined model.

Conclusions

The radiomics model based on biparametric MRI, especially DWI, had good predictive value for LVI of rectal cancer. This model has the potential to facilitate the clinical recognition of LVI in rectal cancer preoperatively.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.CrossRef Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.CrossRef
2.
go back to reference Franke AJ. Skelton WPt, George TJ, Iqbal A: A Comprehensive Review of Randomized Clinical Trials Shaping the Landscape of Rectal Cancer Therapy. Clin Colorectal Cancer. 2021;20(1):1–19.CrossRef Franke AJ. Skelton WPt, George TJ, Iqbal A: A Comprehensive Review of Randomized Clinical Trials Shaping the Landscape of Rectal Cancer Therapy. Clin Colorectal Cancer. 2021;20(1):1–19.CrossRef
3.
go back to reference Alawawdeh A, Krishnan T, Roy A, Karapetis C, Joshi R, Singhal N, Price T. Curative therapy for rectal cancer. Expert Rev Anticancer Ther. 2021;21(2):193–203.CrossRef Alawawdeh A, Krishnan T, Roy A, Karapetis C, Joshi R, Singhal N, Price T. Curative therapy for rectal cancer. Expert Rev Anticancer Ther. 2021;21(2):193–203.CrossRef
4.
go back to reference Wilkinson N. Management of Rectal Cancer. Surg Clin North Am. 2020;100(3):615–28.CrossRef Wilkinson N. Management of Rectal Cancer. Surg Clin North Am. 2020;100(3):615–28.CrossRef
5.
go back to reference Zhang XY, Wang S, Li XT, Wang YP, Shi YJ, Wang L, Wu AW, Sun YS. MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival. Radiology. 2018;289(3):677–85.CrossRef Zhang XY, Wang S, Li XT, Wang YP, Shi YJ, Wang L, Wu AW, Sun YS. MRI of Extramural Venous Invasion in Locally Advanced Rectal Cancer: Relationship to Tumor Recurrence and Overall Survival. Radiology. 2018;289(3):677–85.CrossRef
6.
go back to reference Lee ES, Kim MJ, Park SC, Hur BY, Hyun JH, Chang HJ, Baek JY, Kim SY, Kim DY, Oh JH. Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance. Eur Radiol. 2018;28(2):496–505.CrossRef Lee ES, Kim MJ, Park SC, Hur BY, Hyun JH, Chang HJ, Baek JY, Kim SY, Kim DY, Oh JH. Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance. Eur Radiol. 2018;28(2):496–505.CrossRef
7.
go back to reference Rönnow CF, Arthursson V, Toth E, Krarup PM, Syk I, Thorlacius H. Lymphovascular Infiltration, Not Depth of Invasion, is the Critical Risk Factor of Metastases in Early Colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, Including Validation. Ann Surg. 2022;275(1):e148–54.CrossRef Rönnow CF, Arthursson V, Toth E, Krarup PM, Syk I, Thorlacius H. Lymphovascular Infiltration, Not Depth of Invasion, is the Critical Risk Factor of Metastases in Early Colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, Including Validation. Ann Surg. 2022;275(1):e148–54.CrossRef
8.
go back to reference Horvat N, Petkovska I, Gollub MJ. MR Imaging of Rectal Cancer. Radiol Clin North Am. 2018;56(5):751–74.CrossRef Horvat N, Petkovska I, Gollub MJ. MR Imaging of Rectal Cancer. Radiol Clin North Am. 2018;56(5):751–74.CrossRef
9.
go back to reference Chandramohan A, Mittal R, Dsouza R, Yezzaji H, Eapen A, Simon B, John R, Singh A, Ram TS, Jesudason MR, et al. Prognostic significance of MR identified EMVI, tumour deposits, mesorectal nodes and pelvic side wall disease in locally advanced rectal cancer. Colorectal Dis. 2022;24(4):428-438. Chandramohan A, Mittal R, Dsouza R, Yezzaji H, Eapen A, Simon B, John R, Singh A, Ram TS, Jesudason MR, et al. Prognostic significance of MR identified EMVI, tumour deposits, mesorectal nodes and pelvic side wall disease in locally advanced rectal cancer. Colorectal Dis. 2022;24(4):428-438.
10.
go back to reference Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg. 2003;90(3):355–64.CrossRef Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg. 2003;90(3):355–64.CrossRef
11.
go back to reference Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol. 2022;19(2):132-146. Bera K, Braman N, Gupta A, Velcheti V, Madabhushi A. Predicting cancer outcomes with radiomics and artificial intelligence in radiology. Nat Rev Clin Oncol. 2022;19(2):132-146.
12.
go back to reference Choi YS, Ahn SS, Chang JH, Kang SG, Kim EH, Kim SH, Jain R, Lee SK. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction. Eur Radiol. 2020;30(7):3834–42.CrossRef Choi YS, Ahn SS, Chang JH, Kang SG, Kim EH, Kim SH, Jain R, Lee SK. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction. Eur Radiol. 2020;30(7):3834–42.CrossRef
13.
go back to reference Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn IF, et al. Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin. 2019;69(2):127–57. Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, Allison T, Arnaout O, Abbosh C, Dunn IF, et al. Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin. 2019;69(2):127–57.
14.
go back to reference Hou M, Sun JH. Emerging applications of radiomics in rectal cancer: State of the art and future perspectives. World J Gastroenterol. 2021;27(25):3802–14.CrossRef Hou M, Sun JH. Emerging applications of radiomics in rectal cancer: State of the art and future perspectives. World J Gastroenterol. 2021;27(25):3802–14.CrossRef
15.
go back to reference Akasu T, Iinuma G, Fujita T, Muramatsu Y, Tateishi U, Miyakawa K, Murakami T, Moriyama N. Thin-section MRI with a phased-array coil for preoperative evaluation of pelvic anatomy and tumor extent in patients with rectal cancer. AJR Am J Roentgenol. 2005;184(2):531–8.CrossRef Akasu T, Iinuma G, Fujita T, Muramatsu Y, Tateishi U, Miyakawa K, Murakami T, Moriyama N. Thin-section MRI with a phased-array coil for preoperative evaluation of pelvic anatomy and tumor extent in patients with rectal cancer. AJR Am J Roentgenol. 2005;184(2):531–8.CrossRef
16.
go back to reference Horvat N. Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ: MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management. Radiographics. 2019;39(2):367–87.CrossRef Horvat N. Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ: MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management. Radiographics. 2019;39(2):367–87.CrossRef
17.
go back to reference Moreno CC, Sullivan PS, Mittal PK. Rectal MRI for Cancer Staging and Surveillance. Gastroenterol Clin North Am. 2018;47(3):537–52.CrossRef Moreno CC, Sullivan PS, Mittal PK. Rectal MRI for Cancer Staging and Surveillance. Gastroenterol Clin North Am. 2018;47(3):537–52.CrossRef
18.
go back to reference Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, Fenlon HM, Gollub MJ, Gourtsoyianni S, Halligan S, et al. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2018;28(4):1465–75.CrossRef Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, Fenlon HM, Gollub MJ, Gourtsoyianni S, Halligan S, et al. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2018;28(4):1465–75.CrossRef
19.
go back to reference van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts H. Computational Radiomics System to Decode the Radiographic Phenotype. Can Res. 2017;77(21):e104–7.CrossRef van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts H. Computational Radiomics System to Decode the Radiographic Phenotype. Can Res. 2017;77(21):e104–7.CrossRef
20.
go back to reference Shu Z, Mao D, Song Q, Xu Y, Pang P, Zhang Y. Multiparameter MRI-based radiomics for preoperative prediction of extramural venous invasion in rectal cancer. Eur Radiol. 2022;32(2):1002-1013. Shu Z, Mao D, Song Q, Xu Y, Pang P, Zhang Y. Multiparameter MRI-based radiomics for preoperative prediction of extramural venous invasion in rectal cancer. Eur Radiol. 2022;32(2):1002-1013.
21.
go back to reference McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015;275(3):772–82.CrossRef McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015;275(3):772–82.CrossRef
22.
go back to reference Kanda T, Matsuda M, Oba H, Toyoda K, Furui S. Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015;277(3):924–5.CrossRef Kanda T, Matsuda M, Oba H, Toyoda K, Furui S. Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015;277(3):924–5.CrossRef
23.
go back to reference Gürses B, Böge M, Altınmakas E, Balık E. Multiparametric MRI in rectal cancer. Diagn Interv Radiol. 2019;25(3):175–82.CrossRef Gürses B, Böge M, Altınmakas E, Balık E. Multiparametric MRI in rectal cancer. Diagn Interv Radiol. 2019;25(3):175–82.CrossRef
24.
go back to reference Vliegen RF, Beets GL, von Meyenfeldt MF, Kessels AG, Lemaire EE, van Engelshoven JM, Beets-Tan RG. Rectal cancer: MR imaging in local staging–is gadolinium-based contrast material helpful? Radiology. 2005;234(1):179–88.CrossRef Vliegen RF, Beets GL, von Meyenfeldt MF, Kessels AG, Lemaire EE, van Engelshoven JM, Beets-Tan RG. Rectal cancer: MR imaging in local staging–is gadolinium-based contrast material helpful? Radiology. 2005;234(1):179–88.CrossRef
25.
go back to reference Curvo-Semedo L. Rectal Cancer: Staging. Magn Reson Imaging Clin N Am. 2020;28(1):105–15.CrossRef Curvo-Semedo L. Rectal Cancer: Staging. Magn Reson Imaging Clin N Am. 2020;28(1):105–15.CrossRef
26.
go back to reference Huang J, Chen Y, Zhang Y, Xie J, Liang Y, Yuan W, Zhou T, Gao R, Wen R, Xia Y, et al. Comparison of clinical-computed tomography model with 2D and 3D radiomics models to predict occult peritoneal metastases in advanced gastric cancer. Abdom Radiol (NY). 2022;47(1):66–75.CrossRef Huang J, Chen Y, Zhang Y, Xie J, Liang Y, Yuan W, Zhou T, Gao R, Wen R, Xia Y, et al. Comparison of clinical-computed tomography model with 2D and 3D radiomics models to predict occult peritoneal metastases in advanced gastric cancer. Abdom Radiol (NY). 2022;47(1):66–75.CrossRef
27.
go back to reference Wan Q, Zhou J, Xia X, Hu J, Wang P, Peng Y, Zhang T, Sun J, Song Y, Yang G, et al. Diagnostic Performance of 2D and 3D T2WI-Based Radiomics Features With Machine Learning Algorithms to Distinguish Solid Solitary Pulmonary Lesion. Front Oncol. 2021;11:683587.CrossRef Wan Q, Zhou J, Xia X, Hu J, Wang P, Peng Y, Zhang T, Sun J, Song Y, Yang G, et al. Diagnostic Performance of 2D and 3D T2WI-Based Radiomics Features With Machine Learning Algorithms to Distinguish Solid Solitary Pulmonary Lesion. Front Oncol. 2021;11:683587.CrossRef
28.
go back to reference Zhang Y, He K, Guo Y, Liu X, Yang Q, Zhang C, Xie Y, Mu S, Guo Y, Fu Y, et al. A Novel Multimodal Radiomics Model for Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer. Front Oncol. 2020;10:457.CrossRef Zhang Y, He K, Guo Y, Liu X, Yang Q, Zhang C, Xie Y, Mu S, Guo Y, Fu Y, et al. A Novel Multimodal Radiomics Model for Preoperative Prediction of Lymphovascular Invasion in Rectal Cancer. Front Oncol. 2020;10:457.CrossRef
29.
go back to reference Zhang K, Ren Y, Xu S, Lu W, Xie S, Qu J, Wang X, Shen B, Pang P, Cai X, et al. A clinical-radiomics model incorporating T2-weighted and diffusion-weighted magnetic resonance images predicts the existence of lymphovascular invasion / perineural invasion in patients with colorectal cancer. Med Phys. 2021;48(9):4872–82.CrossRef Zhang K, Ren Y, Xu S, Lu W, Xie S, Qu J, Wang X, Shen B, Pang P, Cai X, et al. A clinical-radiomics model incorporating T2-weighted and diffusion-weighted magnetic resonance images predicts the existence of lymphovascular invasion / perineural invasion in patients with colorectal cancer. Med Phys. 2021;48(9):4872–82.CrossRef
30.
go back to reference Huang A, Yang Y, Shi JY, Li YK, Xu JX, Cheng Y, Gu J. Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer. World J Gastrointest Surg. 2021;13(12):1567–83.CrossRef Huang A, Yang Y, Shi JY, Li YK, Xu JX, Cheng Y, Gu J. Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer. World J Gastrointest Surg. 2021;13(12):1567–83.CrossRef
31.
go back to reference Horvat N, Hope TA, Pickhardt PJ, Petkovska I. Mucinous rectal cancer: concepts and imaging challenges. Abdom Radiol (NY). 2019;44(11):3569–80.CrossRef Horvat N, Hope TA, Pickhardt PJ, Petkovska I. Mucinous rectal cancer: concepts and imaging challenges. Abdom Radiol (NY). 2019;44(11):3569–80.CrossRef
32.
go back to reference Schurink NW, Lambregts DMJ, Beets-Tan RGH. Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol. 2019;92(1096):20180655.CrossRef Schurink NW, Lambregts DMJ, Beets-Tan RGH. Diffusion-weighted imaging in rectal cancer: current applications and future perspectives. Br J Radiol. 2019;92(1096):20180655.CrossRef
33.
go back to reference Kalisz KR, Enzerra MD, Paspulati RM. MRI Evaluation of the Response of Rectal Cancer to Neoadjuvant Chemoradiation Therapy. Radiographics. 2019;39(2):538–56.CrossRef Kalisz KR, Enzerra MD, Paspulati RM. MRI Evaluation of the Response of Rectal Cancer to Neoadjuvant Chemoradiation Therapy. Radiographics. 2019;39(2):538–56.CrossRef
34.
go back to reference Lambregts D, Rao S, Sassen S, Martens M, Heijnen L, Buijsen J, Sosef M, Beets G, Vliegen R, Beets-Tan R. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study. Ann Surg. 2015;262(6):1034–9.CrossRef Lambregts D, Rao S, Sassen S, Martens M, Heijnen L, Buijsen J, Sosef M, Beets G, Vliegen R, Beets-Tan R. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study. Ann Surg. 2015;262(6):1034–9.CrossRef
35.
go back to reference Lambrecht M, Vandecaveye V, De Keyzer F, Roels S, Penninckx F, Van Cutsem E, Filip C, Haustermans K. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys. 2012;82(2):863–70.CrossRef Lambrecht M, Vandecaveye V, De Keyzer F, Roels S, Penninckx F, Van Cutsem E, Filip C, Haustermans K. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. Int J Radiat Oncol Biol Phys. 2012;82(2):863–70.CrossRef
Metadata
Title
Biparametric magnetic resonance imaging-based radiomics features for prediction of lymphovascular invasion in rectal cancer
Authors
Pengfei Tong
Danqi Sun
Guangqiang Chen
Jianming Ni
Yonggang Li
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2023
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-10534-w

Other articles of this Issue 1/2023

BMC Cancer 1/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine